A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
Pompe disease (PD) is a glycogen storage disorder caused by deficient activity of acid alpha-glucosidase (GAA). We sought to review the latest available evidence on the safety and efficacy of recombinant human GAA enzyme replacement therapy (ERT) for late-onset PD (LOPD). Methods: We systematically...
Main Authors: | Alícia Dorneles Dornelles, Ana Paula Pedroso Junges, Tiago Veiga Pereira, Bárbara Corrêa Krug, Candice Beatriz Treter Gonçalves, Juan Clinton Llerena, Priya Sunil Kishnani, Haliton Alves de Oliveira, Ida Vanessa Doederlein Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/21/4828 |
Similar Items
-
Reporting 7 Pompe Patients in Iran
by: Milad Ebrahimi, et al.
Published: (2017-05-01) -
Newborn Screening for Pompe Disease: Pennsylvania Experience
by: Can Ficicioglu, et al.
Published: (2020-11-01) -
From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease
by: Valentina Sánchez-Porras, et al.
Published: (2023-08-01) -
Pompe disease - What do we currently know about the disease?
by: Edyta Białowąs, et al.
Published: (2023-02-01) -
GAA variants associated with reduced enzymatic activity but lack of Pompe-related symptoms, incidentally identified by exome sequencing
by: Anna Malekkou, et al.
Published: (2023-09-01)